Estados Unidos - inglés - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 30 mg - diltiazem hydrochloride tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. diltiazem hydrochloride tablets are contraindicated in (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker, (2) patients with second- or third-degree av block except in the presence of a functioning ventricular pacemaker, (3) patients with hypotension (less than 90 mm hg systolic), (4) patients who have demonstrated hypersensitivity to the drug, and (5) patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.

Estados Unidos - inglés - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 120 mg - hypertension: diltiazem hydrochloride extended-release capsules are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive medications. chronic stable angina: diltiazem hydrochloride extended-release capsules are indicated for the treatment of chronic stable angina. diltiazem is contraindicated in: • patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker  • patients with second- or third-degree av block except in the presence of a functioning ventricular pacemaker • patients with severe hypotension (less than 90 mm hg systolic)  • patients who have demonstrated hypersensitivity to the drug • patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.

Estados Unidos - inglés - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 120 mg - diltiazem hydrochloride extended-release capsules is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive medications. diltiazem hydrochloride extended-release capsules is indicated for the treatment of chronic stable angina. diltiazem is contraindicated in (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker, (2) patients with second- or third-degree av block except in the presence of a functioning ventricular pacemaker, (3) patients with severe hypotension (less than 90 mm hg systolic), (4) patients who have demonstrated hypersensitivity to the drug, and (5) patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 360 mg - capsule, modified release - excipient ingredients: purified talc; sodium lauryl sulfate; methacrylic acid copolymer; povidone; simethicone; diethyl phthalate; tributyl acetylcitrate; maize starch; sucrose; titanium dioxide; brilliant blue fcf; potable water; gelatin; silicon dioxide - diltiazem sandoz cd is indicated for the treatment of hypertension. diltiazem sandoz cd is also indicated for the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. since the safety and efficacy of cd capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 240 mg - capsule, modified release - excipient ingredients: ethylcellulose; simethicone; purified talc; castor oil; tributyl acetylcitrate; white beeswax; methacrylic acid copolymer; titanium dioxide; gelatin; colloidal anhydrous silica; brilliant blue fcf; stearic acid; fumaric acid; maize starch; sucrose - diltiazem sandoz cd is indicated for the treatment of hypertension. diltiazem sandoz cd is also indicated for the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. since the safety and efficacy of cd capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 180 mg - capsule, modified release - excipient ingredients: fumaric acid; gelatin; methacrylic acid copolymer; brilliant blue fcf; white beeswax; stearic acid; colloidal anhydrous silica; simethicone; ethylcellulose; titanium dioxide; tributyl acetylcitrate; castor oil; purified talc; maize starch; sucrose - diltiazem sandoz cd is indicated for the treatment of hypertension. diltiazem sandoz cd is also indicated for the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. since the safety and efficacy of cd capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.

Estados Unidos - inglés - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 120 mg - diltiazem hydrochloride tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. diltiazem hydrochloride tablets are contraindicated in: - patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker - patients with second – or third-degree av block except in the presence of a functioning ventricular pacemaker - patients with hypotension (less than 90 mm hg systolic) - patients who have demonstrated hypersensitivity to the drug - patients which acute myocardial infarction and pulmonary congestion documents by x-ray on admission

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diltiazem hydrochloride 120.12mg - modified release capsule - 120 mg - active: diltiazem hydrochloride 120.12mg excipient: capsugel light blue turquoise blue 0588 methacrylic acid copolymer methylcellulose microcrystalline cellulose polysorbate 80 purified talc tributyl citrate - diltiazem cd is indicated for the treatment of hypertension either alone or in combination with other antihypertensive medications such as diuretics.

Estados Unidos - inglés - NLM (National Library of Medicine)

apotex corp. - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 120 mg - dilt-xr [diltiazem hydrochloride extended-release capsules, usp (once-a-day dosage)] are indicated for the treatment of hypertension. diltiazem hydrochloride may be used alone or in combination with other antihypertensive medications, such as diuretics. dilt-xr [diltiazem hydrochloride extended-release capsules, usp (once-a-day dosage)] are indicated for the management of chronic stable angina. diltiazem hydrochloride is contraindicated in: (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker; (2) patients with second or third degree av block except in the presence of a functioning ventricular pacemaker; (3) patients with hypotension (less than 90 mmhg systolic); (4) patients who have demonstrated hypersensitivity to the drug; and (5) patients with acute myocardial infarction and pulmonary congestion as documented by x-ray on admission.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diltiazem hydrochloride 180.1mg - modified release capsule - 180 mg - active: diltiazem hydrochloride 180.1mg excipient: capsugel light blue turquoise blue 0588 methacrylic acid copolymer methylcellulose microcrystalline cellulose polysorbate 80 purified talc tributyl citrate - diltiazem cd is indicated for the treatment of hypertension either alone or in combination with other antihypertensive medications such as diuretics.